Coya Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
13.00
|
|
Average Rating
|
4.80
|
|
# Strong Buys
|
4
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-09-30
|
-0.42
|
-0.26
|
0.16
|
37.35%
|
|
2024-06-30
|
-0.14
|
-0.19
|
-0.05
|
-35.71%
|
|
2024-03-31
|
-0.29
|
-0.35
|
-0.06
|
-20.69%
|
|
2023-12-31
|
0.26
|
0.28
|
0.02
|
7.69%
|
|
2023-09-30
|
-0.37
|
-0.48
|
-0.11
|
-29.73%
|
|
2023-06-30
|
-0.32
|
-0.31
|
0.01
|
3.13%
|
|
2023-03-31
|
-0.43
|
-0.28
|
0.15
|
34.88%
|
|
2022-12-31
|
0.00
|
-0.31
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-09-30
|
-0.80
|
|
2023-12-31
|
-0.79
|
|
2022-12-31
|
-0.51
|